Global Aneroid Sphygmomanometer Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2033

Aneroid Sphygmomanometer Market Size

• The global aneroid sphygmomanometer market size was valued at USD 2.63 billion in 2025and is expected to reach USD 5.58 billion by 2033, at a CAGR of 9.87% during the forecast period
• The market growth is largely fueled by the rising prevalence of hypertension and cardiovascular disorders, along with increasing emphasis on routine blood pressure monitoring across hospitals, clinics, and homecare settings, leading to greater adoption of aneroid sphygmomanometer devices worldwide. Technological improvements in cuff design, durability, and measurement accuracy are further supporting market expansion
• Furthermore, growing consumer and healthcare provider demand for cost-effective, portable, and easy-to-use blood pressure monitoring solutions is establishing aneroid sphygmomanometers as a preferred choice in both professional and personal healthcare environments. These converging factors are accelerating the uptake of Aneroid Sphygmomanometer solutions, thereby significantly boosting the industry's growth

Aneroid Sphygmomanometer Market Analysis

• Aneroid sphygmomanometers, widely used for non-invasive blood pressure measurement in hospitals, clinics, ambulatory care centers, and homecare settings, are increasingly vital components of modern healthcare systems due to their portability, affordability, reliable manual readings, and suitability for routine cardiovascular monitoring
• The escalating demand for aneroid sphygmomanometers is primarily fueled by the growing global burden of hypertension, increasing awareness regarding preventive healthcare, rising need for regular blood pressure screening, and expanding use of manual monitoring devices in resource-limited and professional healthcare environments
• North America dominated the aneroid sphygmomanometer market with the largest revenue share of 37.80% in 2025, supported by advanced healthcare infrastructure, high screening rates for cardiovascular diseases, strong presence of leading medical device manufacturers, and widespread adoption across hospitals, clinics, and home monitoring settings, with the U.S. experiencing substantial demand for durable and clinically accurate devices
• Asia-Pacific is expected to be the fastest growing region in the aneroid sphygmomanometer market during the forecast period due to rising healthcare expenditure, increasing hypertension prevalence, expanding primary healthcare networks, and growing awareness of regular blood pressure monitoring across countries such as China, India, and Japan
• The Electronic Sphygmomanometer segment dominated the largest market revenue share of 49.6% in 2025, driven by increasing demand for automated blood pressure monitoring devices across hospitals, clinics, and homecare settings

Report Scope and Aneroid Sphygmomanometer Market Segmentation

Aneroid Sphygmomanometer Market Trends

“Growing Demand for Portable and Durable Manual Blood Pressure Monitoring Devices”

• A significant and accelerating trend in the global Aneroid Sphygmomanometer market is the rising demand for portable, durable, and cost-effective manual blood pressure monitoring devices across hospitals, clinics, ambulatory centers, and home healthcare settings. These devices remain widely preferred for their reliability, ease of use, and independence from battery power
• For instance, healthcare providers and outpatient clinics continue to adopt professional aneroid sphygmomanometers from companies such as Welch Allyn and ADC (American Diagnostic Corporation) due to their rugged design, accurate pressure measurement, and suitability for frequent clinical use
• The increasing popularity of home healthcare and remote patient monitoring is also driving demand for compact manual blood pressure devices that can be easily transported and used by trained caregivers
• Manufacturers are focusing on ergonomic cuff designs, shock-resistant gauges, latex-free components, and improved calibration stability to enhance user comfort and device longevity
• Rising demand from emerging economies, where affordability and limited electricity access remain important considerations, is further supporting the continued adoption of aneroid devices over fully digital alternatives
• This trend toward dependable, economical, and portable blood pressure monitoring solutions is sustaining the relevance of aneroid sphygmomanometers in modern healthcare systems

Aneroid Sphygmomanometer Market Dynamics

Driver

“Increasing Prevalence of Hypertension and Expansion of Preventive Healthcare Screening”

• The growing global burden of hypertension and cardiovascular diseases is a major driver supporting the growth of the Aneroid Sphygmomanometer market, as regular blood pressure monitoring becomes increasingly essential in preventive and routine healthcare
• For instance, hospitals, primary care clinics, and community health programs are expanding blood pressure screening initiatives using manual sphygmomanometers, particularly in cost-sensitive settings where dependable and affordable devices are required for mass screening
• Rising awareness regarding early detection of hypertension is encouraging healthcare providers to maintain routine blood pressure checks during outpatient visits, workplace wellness programs, and public health campaigns
• Expanding healthcare infrastructure in developing economies and increased investment in primary care services are also creating stronger demand for diagnostic essentials such as manual blood pressure monitors
• In addition, the growing elderly population, which faces higher cardiovascular risk, is contributing to sustained demand for regular and accurate blood pressure assessment tools

Restraint/Challenge

“Calibration Requirements, User Dependency, and Competition from Digital Devices”

• Regular calibration and maintenance requirements remain a key challenge for aneroid sphygmomanometers, as inaccurate readings may occur over time if gauges are not periodically checked and serviced
• For instance, in smaller clinics and rural healthcare centers, devices may continue to be used without timely recalibration or cuff replacement, which can affect measurement accuracy and clinical decision-making
• Accurate use of manual blood pressure devices also depends heavily on operator skill, including proper cuff placement, stethoscope technique, and interpretation of Korotkoff sounds, creating variability between users
• Increasing consumer preference for automated digital blood pressure monitors, especially for home use, is intensifying competition and reducing adoption among untrained users seeking convenience
• Addressing these challenges through improved training, durable designs, easier calibration systems, and hybrid professional-use models will be essential for long-term market growth

Aneroid Sphygmomanometer Market Scope

The market is segmented on the basis of product and application.

• By Product

On the basis of product, the Aneroid Sphygmomanometer market is segmented into Electronic Sphygmomanometer, Aneroid Sphygmomanometer, and Mercury Sphygmomanometer. The Electronic Sphygmomanometer segment dominated the largest market revenue share of 49.6% in 2025, driven by increasing demand for automated blood pressure monitoring devices across hospitals, clinics, and homecare settings. These devices offer ease of use, digital displays, memory storage, and improved convenience compared to manual systems. Rising prevalence of hypertension globally is significantly boosting demand for regular monitoring solutions. Healthcare providers increasingly prefer electronic devices for faster readings and reduced observer error. Growth of telehealth and remote patient monitoring is further supporting adoption. Technological advancements such as Bluetooth connectivity and smartphone integration are enhancing product appeal. Increasing elderly population and chronic disease burden are also contributing to growth. Expansion of preventive healthcare awareness is driving home-use demand. Overall, electronic sphygmomanometers remain the dominant product segment due to convenience and digital functionality.

The Aneroid Sphygmomanometer segment is expected to witness the fastest growth rate of 8.8% CAGR from 2026 to 2033, driven by rising preference for accurate, portable, and cost-effective manual blood pressure monitoring devices in professional healthcare settings. Aneroid devices are widely used by physicians and nurses due to their reliability and independence from batteries or electricity. Growing demand in emerging economies where affordability is critical is boosting adoption. Hospitals and clinics continue to prefer aneroid systems for routine examinations. Technological improvements in gauge precision and cuff durability are enhancing performance. Increased training of healthcare professionals in manual BP measurement supports usage. Rising expansion of primary care centers globally is another growth factor. Compact design and ease of transport make them suitable for field healthcare services. Strong replacement demand from aging mercury devices is also accelerating sales. These factors position aneroid sphygmomanometers as the fastest-growing product segment.

• By Application

On the basis of application, the Aneroid Sphygmomanometer market is segmented into Hospital, Clinic, Family, and Other. The Hospital segment accounted for the largest market revenue share of 44.3% in 2025, driven by high patient volumes, continuous blood pressure monitoring needs, and availability of trained healthcare professionals. Hospitals require reliable sphygmomanometers for emergency rooms, inpatient wards, surgical units, and outpatient departments. Increasing admissions related to cardiovascular disease and hypertension are significantly supporting demand. Institutional procurement of both electronic and manual devices strengthens revenue generation. Hospitals also maintain frequent replacement cycles due to heavy equipment usage. Rising investments in healthcare infrastructure and modernization programs further support growth. Demand for accurate monitoring in critical care units remains a major driver. Expansion of multispecialty hospitals in developing economies is also contributing. Overall, hospitals remain the leading application segment due to broad and continuous device utilization.

The Family segment is anticipated to witness the fastest growth rate of 10.4% CAGR from 2026 to 2033, driven by increasing awareness of preventive healthcare and rising adoption of home blood pressure monitoring devices. Consumers are increasingly tracking blood pressure regularly to manage hypertension and cardiovascular risks. Growing elderly population and chronic disease prevalence are boosting home-use demand. Easy availability of affordable monitoring devices through retail and e-commerce channels supports expansion. Telemedicine growth is encouraging patients to share home readings with physicians remotely. User-friendly digital devices are improving adoption among non-clinical users. Rising disposable income in developing countries is also contributing to segment growth. Health campaigns promoting regular BP checks further strengthen demand. Compact and portable products are ideal for family use. These factors collectively make the Family segment the fastest-growing application category.

Aneroid Sphygmomanometer Market Regional Analysis

• North America dominated the aneroid sphygmomanometer market with the largest revenue share of 37.80% in 2025, supported by advanced healthcare infrastructure, high screening rates for cardiovascular diseases, strong presence of leading medical device manufacturers, and widespread adoption across hospitals, clinics, and home monitoring settings. The region benefits from established preventive healthcare programs and routine blood pressure screening initiatives that continue to drive steady product demand
• Healthcare providers and consumers in the region highly value the durability, portability, and clinical accuracy offered by aneroid sphygmomanometers for routine blood pressure assessment. Strong preference for cost-effective manual monitoring devices, especially in physician offices, emergency care units, and ambulatory settings, is further contributing to market growth
• This widespread adoption is further supported by favorable reimbursement systems, a highly aware patient population, and growing demand for home-based cardiovascular monitoring, establishing aneroid sphygmomanometers as an essential diagnostic tool across both professional and personal healthcare environments

U.S. Aneroid Sphygmomanometer Market Insight

The U.S. aneroid sphygmomanometer market captured the largest revenue share within North America in 2025, driven by substantial demand for durable and clinically accurate devices across hospitals, outpatient centers, physician offices, and home-care settings. Rising prevalence of hypertension and cardiovascular disorders is increasing the need for regular blood pressure monitoring nationwide. Healthcare professionals continue to rely on aneroid sphygmomanometers for routine examinations due to their portability, ease of use, and lower maintenance requirements compared with digital alternatives in certain clinical environments. In addition, growing consumer adoption of home monitoring devices is further propelling market expansion in the U.S.

Europe Aneroid Sphygmomanometer Market Insight

The Europe aneroid sphygmomanometer market is projected to expand at a substantial CAGR throughout the forecast period, primarily driven by increasing prevalence of chronic cardiovascular conditions, aging populations, and strong preventive healthcare systems. The region is witnessing sustained demand for reliable manual blood pressure monitoring devices across hospitals, general practice clinics, pharmacies, and community healthcare centers. Growing focus on early hypertension detection and routine patient screening is contributing significantly to market expansion across Europe.

U.K. Aneroid Sphygmomanometer Market Insight

The U.K. aneroid sphygmomanometer market is anticipated to grow at a noteworthy CAGR during the forecast period, driven by increasing awareness of cardiovascular health and expanding use of blood pressure monitoring in primary care settings. Hospitals, GP clinics, and home healthcare providers are increasingly adopting dependable and easy-to-use monitoring devices. Continued emphasis on early diagnosis of hypertension and population health management programs is expected to stimulate market growth in the U.K.

Germany Aneroid Sphygmomanometer Market Insight

The Germany aneroid sphygmomanometer market expected to expand at a considerable CAGR during the forecast period, fueled by advanced healthcare infrastructure, strong diagnostic standards, and rising demand for precision monitoring equipment. Germany’s well-developed hospital systems and outpatient care networks promote widespread adoption of aneroid sphygmomanometers in routine examinations and chronic disease management. Demand for high-quality, long-lasting, and clinically validated devices is also supporting market growth.

Asia-Pacific Aneroid Sphygmomanometer Market Insight

The Asia-Pacific aneroid sphygmomanometer market is poised to grow at the fastest CAGR during the forecast period, driven by rising healthcare expenditure, increasing hypertension prevalence, expanding primary healthcare networks, and growing awareness of regular blood pressure monitoring across countries such as China, India, and Japan. The region is witnessing rapid growth in hospitals, community clinics, pharmacies, and home-care settings. Government initiatives promoting preventive healthcare, along with improved access to affordable medical devices, are accelerating market penetration across urban and rural populations.

Japan Aneroid Sphygmomanometer Market Insight

The Japan aneroid sphygmomanometer market is gaining momentum due to the country’s aging population, advanced healthcare ecosystem, and strong focus on chronic disease prevention. Japanese healthcare providers emphasize regular cardiovascular screening and home-based monitoring for elderly patients. Demand for compact, accurate, and durable blood pressure devices is supporting market growth across hospitals, clinics, and residential care settings.

China Aneroid Sphygmomanometer Market Insight

The China aneroid sphygmomanometer market accounted for the largest market revenue share in Asia Pacific in 2025, attributed to the country’s growing healthcare infrastructure, rising hypertension burden, and expanding public health awareness programs. China is witnessing strong adoption of blood pressure monitoring devices across hospitals, community health centers, and households. Increasing affordability of medical devices, alongside domestic manufacturing capabilities and large-scale screening initiatives, are key factors propelling the market in the country.

Aneroid Sphygmomanometer Market Share

The Aneroid Sphygmomanometer industry is primarily led by well-established companies, including:

• Omron Corporation (Japan)
• A&D Company, Limited (Japan)
• American Diagnostic Corporation (ADC) (U.S.)
• Rudolf Riester GmbH (Germany)
• Briggs Healthcare (U.S.)
• Prestige Medical (U.S.)
• GF Health Products, Inc. (U.S.)
• Microlife Corporation (Switzerland)
• Beurer GmbH (Germany)
• Rossmax International Ltd. (Taiwan)
• Spengler SAS (France)
• SunTech Medical, Inc. (U.S.)
• HEINE Optotechnik GmbH & Co. KG (Germany)
• Medline Industries, LP (U.S.)
• Trimline Medical Products (U.S.)
• seca GmbH & Co. KG (Germany)
• Spirit Medical Co., Ltd. (Taiwan)
• Yuwell-Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (China)
• Bosch + Sohn GmbH u. Co. KG (Germany)

Latest Developments in Global Aneroid Sphygmomanometer Market

• In March 2021, the American Heart Association reaffirmed recommendations supporting the continued use of clinically validated manual blood pressure devices, including aneroid sphygmomanometers, in healthcare settings where trained professionals require accurate auscultatory blood pressure measurement. This reinforced the importance of aneroid devices in hospitals and clinics worldwide
• In September 2021, Rudolf Riester GmbH announced continued expansion of its professional diagnostic device portfolio, including upgraded aneroid sphygmomanometer models designed with shock-protected mechanisms and improved dial readability for physicians and emergency care professionals
• In May 2022, Baxter International completed its acquisition of Hillrom, bringing Welch Allyn’s blood pressure monitoring portfolio under Baxter’s medical product ecosystem. This development strengthened global distribution of Welch Allyn aneroid sphygmomanometers used widely in hospitals and physician offices
• In October 2022, American Diagnostic Corporation (ADC) introduced updated versions of its Prosphyg aneroid sphygmomanometer line with improved cuff materials, enhanced inflation systems, and clearer gauge visibility to support routine clinical blood pressure measurement
• In April 2023, SunTech Medical expanded its professional blood pressure diagnostics portfolio by promoting integrated manual and hybrid monitoring solutions, including aneroid-based systems for hospitals seeking dependable non-digital measurement tools alongside automated devices
• In August 2023, Briggs Healthcare announced expanded availability of its professional aneroid sphygmomanometer range for outpatient clinics, homecare providers, and long-term care centers, responding to increasing demand for durable manual blood pressure devices
• In February 2024, MDF Instruments launched enhanced calibration-support and service programs for its aneroid sphygmomanometer product range, helping healthcare providers maintain measurement accuracy and comply with equipment quality standards
• In November 2024, Rudolf Riester GmbH introduced refreshed design updates to selected Ri-san aneroid sphygmomanometer models, featuring ergonomic inflation bulbs, latex-free cuffs, and improved portability for mobile clinicians
• In January 2025, healthcare procurement networks in multiple regions increased purchases of aneroid sphygmomanometers as facilities strengthened emergency preparedness plans by maintaining manual blood pressure devices as reliable backups to electronic monitors

SKU-68934